ClinicalTrials.gg
WithdrawnNCT06520696MILCUpdated Oct 16, 2026

MILC: A Comprehensive Mobile Application That Addresses the Breastfeeding Challenges of Low-income Hispanic Mothers

An interventional study of MILC application and Usual care in Breastfeeding, Exclusive, sponsored by Benten Technologies, Inc.. Withdrawn at 3 sites in United States. Open to female participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-16.

Sponsored by Benten Technologies, Inc. · Not applicable, Interventional, and Supportive care

How we know

Why this study was withdrawn
Lapse in SBIR reauthorization and lack of funding
Updated Oct 16, 2026Now WithdrawnStart date moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
18 Years to 44 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 251 studies in Breast Feeding with a site in United States — 43 open to participants now, 49 under way, none of them phase 3. Breast Feeding · United States.

Enrollment
189th of 202
0 · median 83
Started
2025
with 15 others
No phase
164 of 251
26 open now
Registered
222nd of 251
by date

Among the 251 studies in Breast Feeding with a site in United States, this one is the 189th largest by enrollment of the 202 interventional ones that give a count, is one of 16 that started in 2025, is one of 164 with no phase, and was the 222nd registered.

Breast Feeding

1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.

Browse Breast Feeding studies →

Open to participants now

43 of the 251 studies in Breast Feeding with a site in United States are open now. Recruiting first, the newest first:

38 more — sign in →

All 43 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.

This study: 18 Years to 44 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 251 studies in Breast Feeding with a site in United States, or all of them as a file.
02

Study summary

The innovative platform MILC is designed to provide an integrated and comprehensive professional and social support network with personalized breastfeeding (BF) education to target exclusive breastfeeding (EBF) and any BF behaviors in low-income Hispanic women. Formative research conducted for the development of MILC and results from pilot testing will help guide the completion of the development and testing of this prototype that specifically caters to Hispanic women. In the long term, MILC has the potential to increase the rates of EBF and any BF up to 12 months.

Read the detailed description

Breastfeeding (BF) is positively associated with health benefits for infants. It reduces an infant's risks for various conditions such as respiratory tract infections, non-specific gastroenteritis, diarrhea, asthma, and sudden infant death syndrome (SIDS).

Despite high breastfeeding (BF) initiation of approximately 80% among the Hispanic population in the United States (US), less than 25% of infants were exclusively breastfed (EBF) through 6 months, further perpetuating ethnic disparities in chronic diseases such as diabetes, obesity, and hypertension. Hispanic women are more likely to supplement feeding with formula, than non-Hispanic or African American (AA) mothers. Research has reported that barriers such as insufficient BF education, lack of BF technical support (i.e. latching issues, sore nipples), returning to work, easy access to free or discounted formula milk from Women Infants and Children (WIC), lack of social support, perceived inconvenience, cultural belief that both formula and breastmilk (los-dos) is best for the babies, perception that the infant is not satiated, and embarrassment associated with breastfeeding result in premature weaning off BF among low-income Hispanic mothers. Therefore, increasing the duration of EBF and continuous BF among low-income Hispanic women would require an innovative and comprehensive approach that addresses the diverse range of barriers listed above.

The investigators hypothesize that MILC will show significantly higher percentages of BF mothers in the intervention group at each time (1 month, 3 months, and 6 months) point compared with the control group. In the short term, MILC will be shown to be usable and acceptable by Hispanic BF mothers to receive BF support, education, and guidance from primary care providers (PCP) and certified lactation consultants/international board certified lactation consultants (CLC/IBCLC). In the long term, the impact of MILC will increase the rates of EBF for up to 6 months along with increasing rates of any BF up to 12 months.

03

Conditions studied

  • Breastfeeding, Exclusive

Browse trials for

Keywords

  • breastfeeding
  • breastfeeding education
  • breastfeeding support
  • exclusive breastfeeding
04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Eligibility criteria

Inclusion Criteria for focus groups:

  • Mothers who successfully exclusively breastfed for up to 6 months, at least one child OR mothers who attempted EBF but were unsuccessful at breastfeeding, in the past 3 years
  • Self-identify as Hispanic
  • Be WIC-eligible
  • Voluntarily consent
  • Speak English

Inclusion Criteria for Randomized Control Trial (RCT):

  • In their late third trimester (approximately 4 weeks from delivery)
  • Can initiate BF immediately
  • Self-identify as Hispanic
  • Be WIC-eligible
  • Voluntarily consent
  • Not have psychiatric hospitalization within the last 3 months
  • Not have current or suicidal thoughts or past attempts
  • Own a smartphone device
  • Speak English

Exclusion Criteria for focus groups and Randomized Control Trial (RCT):

  1. Participants who are under the age of 18 or over 44
  2. Women experiencing a fetal demise or infant death
  3. Women who report the following conditions also will be excluded:

    • (HIV)
    • Taking antiretroviral medication or chemotherapy agents
    • Untreated, active tuberculosis
    • T-Cell lymphotropic virus type I or type II
    • Illicit drug use
    • Receiving radiation therapy
    • Exposed to anthrax
    • Undergone breast surgery
    • Known exposure to environmental toxins
    • Active and C
    • Prescription drug use incompatible with lactation
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

HIV

The human immunodeficiency virus, which weakens the immune system.

Many studies now accept people whose HIV is controlled on treatment, judged by the viral load and the CD4 count. Check the limits this study sets.

Hepatitis B tests

Hepatitis B is a virus that infects the liver. These are separate tests: HBsAg positive usually means a current infection (a recent vaccination can briefly cause it too); total anti-HBc (HBcAb) positive means an infection now or in the past; HBV DNA measures how much virus is in the blood.

Some studies accept a past infection if HBV DNA is undetectable, sometimes with antiviral medicine during the study. Check what this study allows.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Experimental
    Intervention group: MILC application

    Eligible Hispanic participants in their third trimester will be recruited for the study. The intervention group will receive standard WIC services plus the MILC application.

    Behavioral: MILC application

  • Experimental
    Control Group: Usual Care

    Participants in the control group will receive care as usual with standard breastfeeding services from the WIC program.

    Behavioral: Usual care

Interventions

  • BehavioralMILC application

    Eligible Hispanic participants in their third trimester will be recruited for the study. Intervention group will receive standard WIC services plus the MILC application. Standard WIC support includes on-site lactation consultation, bilingual peer counseling, weekly peer support meetings, free breast pump, and enhanced food package for BF mothers. If a participant has trouble with breastfeeding, she will be referred to a home-visiting breastfeeding peer counselor in the area. Participants will be asked to participate in the periodic follow-up assessments at 1, 3 and 6 months along with demonstrating breastfeeding via MILC app. Participants will send in 1 BF video per month using the MILC app to verify continued BF and fill out monthly self-report to verify EBF. Participants in the incentive group will receive escalating monthly points as incentives for every additional month of continued BF and EBF.

  • BehavioralUsual care

    Participants in the control group will receive care as usual with standard breastfeeding services from the WIC program and will be asked to participate in the periodic follow-up assessments at 1, 3 and 6 months. Participants in the control group can receive financial compensation for the completion of assessments. This is necessary to maximize retention and adherence to the monthly assessment schedule, provide comparable remuneration as the incentive group, and minimize demoralization of control group participants following treatment assignment. All participants are informed of the differential group procedures during the randomization consent process. In addition to the follow-up assessment, control group will also complete a monthly self-report on BF status (both for EBF and "any BF"). For attention control purposes in this group, participants will be referred to a mobile app for tracking the baby's milestones called Baby Connect.

06

What researchers measure

Primary outcomes

  1. Exclusive breastfeeding

    Investigators will assess if participants are breastfeeding exclusively (EBF)through monthly self-reported information. Investigators will record information on EBF at 1 month, 3 months and 6 months among women in the intervention arm.

    Time frame: 1 month, 3 months and 6 months

  2. Any breastfeeding rate(EBF)

    Investigators will assess if participants are continuous breastfeeding through monthly breastfeeding videos uploaded in the system. Investigators will report information on any breastfeeding at 1 month, 3 months and 6 months.

    Time frame: 1 month, 3 months and 6 months

Secondary outcomes

  1. Infant weight (Medical outcomes)

    Infant's weight using medical report collected at 1 month, 3 month and 6 months

    Time frame: Baseline, 1 month, 3 months and 6 months

  2. Emergency department visit (Medical outcomes)

    Number of emergency department visited for infant will be collected at 1 month, 3 month and 6 months

    Time frame: Baseline, 1 month, 3 months and 6 months

Other outcomes

  1. Latching

    It will be assessed using LATCH breastfeeding assessment scale. LATCH stands for latch, audible swallowing, type of nipple, comfort and hold. Each component is scored from 0-2. A LATCH score of 0-3 is regarded as poor, 4-7 as moderate, and 8-10 as good.

    Time frame: Baseline, 1 month, 3 months and 6 months

  2. BF history & attitudes questionnaire

    New survey based on constructs that potentially moderate BF

    Time frame: Baseline, 1 month, 3 months and 6 months

  3. Self-Efficacy Scale

    It will be assessed using the BF Self-Efficacy Scale Short Form (BSES-SF). The BSES-SF is a 14-item self-administered instrument derived from the original 33-item BSES that measures breastfeeding confidence. Total scores range from 14 to 70, with higher scores reflecting more significant levels of breastfeeding self-efficacy.

    Time frame: Baseline, 1 month, 3 months and 6 months

  4. Iowa Infant Feeding Attitude

    It will be collected using the Iowa infant feeding attitudes scale (IIFAS). The scale is composed of 17 items for assessing attitude towards BF. The total IIFAS score can range from 17 to 85 with higher scores reflecting positive attitude towards breastfeeding

    Time frame: Baseline, 1 month, 3 months and 6 months

  5. Acculturation

    It will be assessed by using the Acculturation Rating Scale for Mexican Americans II. The scale contains 48 items to which participants respond on a 5-point Likert scale ranging from "Not at all" to "Extremely often or almost always," with higher scores indicating greater cultural orientation.

    Time frame: Baseline, 1 month, 3 months and 6 months

  6. Postnatal depression

    It will be assessed using Edinburgh Postnatal depression Scale (EPDS). The EPDS has a maximum score of 30; a score of 10 or more may indicate possible depression of varying severity.

    Time frame: Baseline, 1 month, 3 months and 6 months

  7. Usability

    System Usability Scale (SUS)survey will be used to assess usability of the MILC app. A SUS score above 68 would be considered above average and anything below 68 is below average.

    Time frame: Month 6 postpartum

  8. Acceptance and Adoption

    Technology Acceptance Model (TAM) will be used to assess acceptance of MILC app

    Time frame: Month 6 postpartum

07

Study locations

3 sites
  • UCONN Health
    Farmington, Connecticut 06030-8084, United States
  • RTI International
    Research Triangle Park, North Carolina 27709-2194, United States
  • Temple University
    Philadelphia, Pennsylvania 19134, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Ran from Jun 2025 to primary completion in Jun 2025, 0 months.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 16, 2026: start Aug 2024 → Jun 2025 and primary completion Feb 2025 → Jun 2025.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Jul 20, 2024
First posted
Jul 25, 2024
StartActual
Jun 30, 2025was Aug 2024
Primary completionActual
Jun 30, 2025was Feb 2025
CompletionActual
Jun 30, 2025
Last update
Oct 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Withdrawn Lapse in SBIR reauthorization and lack of funding
changed Oct 16, 2026
Start date
Aug 2024→Jun 30, 2025 (actual)
Oct 16, 2026
Primary completion
Feb 2025→Jun 30, 2025 (actual)
Oct 16, 2026
Enrollment
178 (estimated)→0 (actual)
Oct 16, 2026
Show all 1 update
  1. Oct 16, 2026
    Not yet recruiting→Withdrawn
    Why stopped Lapse in SBIR reauthorization and lack of funding
    Start date Aug 2024→Jun 30, 2025 (now actual)
    Primary completion Feb 2025→Jun 30, 2025 (now actual)
    Enrollment 178 (estimated)→0 (actual)
    + 4 other changes: verification date, contact details, site details and index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT06520696
Lead sponsor
Benten Technologies, Inc.
Responsible party
Tony Ma (Project Director or Principal Investigator, Benten Technologies, Inc.) — Principal investigator
First posted
Jul 25, 2024
Start date
Jun 30, 2025
Primary completion
Jun 30, 2025
Completion
Jun 30, 2025
Last update
Oct 16, 2026

Study contacts

Tony Ma, MS
principal investigator · Benten Technologies
Yukiko Washio, PhD
principal investigator · RTI International

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion